Canada Pension Plan Investment Board’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$129M Buy
+661,545
New +$128M 0.08% 220
2019
Q3
Sell
-296,300
Closed -$24.5M 1191
2019
Q2
$24.5M Hold
296,300
0.05% 301
2019
Q1
$24M Sell
296,300
-358,500
-55% -$28.3M 0.05% 340
2018
Q4
$49.7M Sell
654,800
-403,900
-38% -$31.5M 0.11% 149
2018
Q3
$83.8M Hold
1,058,700
0.15% 114
2018
Q2
$74.3M Sell
1,058,700
-94,100
-8% -$6.77M 0.14% 129
2018
Q1
$80.6M Buy
1,152,800
+510,600
+80% +$35.4M 0.14% 141
2017
Q4
$44.6M Buy
642,200
+567,949
+765% +$38.3M 0.08% 213
2017
Q3
$5.03M Buy
74,251
+74,201
+148,402% +$4.69M 0.01% 662
2017
Q2
$3K Sell
50
-885,600
-100% -$57.8M ﹤0.01% 1091
2017
Q1
$55.2M Hold
885,650
0.14% 115
2016
Q4
$48.4M Hold
885,650
0.18% 94
2016
Q3
$58.2M Buy
885,650
+453,250
+105% +$29.6M 0.21% 93
2016
Q2
$26.1M Buy
+432,400
New +$25.1M 0.11% 159
2015
Q1
Sell
-50,000
Closed -$3.52M 1131
2014
Q4
$3.52M Buy
+50,000
New +$3.58M 0.01% 677
2013
Q4
Sell
-10,146
Closed -$527K 1230
2013
Q3
$527K Hold
10,146
﹤0.01% 777
2013
Q2
$480K Buy
+10,146
New +$517K ﹤0.01% 683

Other funds holding AZN

Canada Pension Plan Investment Board's AZN Position: Q1 2026 in Review

Canada Pension Plan Investment Board opened a new position in AstraZeneca (AZN) in Q1 2026: 661,545 shares worth $129M. The stake represents 0.08% of the portfolio and ranks #220 among its holdings. This is a return to the name: Canada Pension Plan Investment Board previously reported a position in AZN as recently as Q2 2019.

Canada Pension Plan Investment Board first reported a position in AZN in Q2 2013 and has held it in 17 quarters since. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Canada Pension Plan Investment Board held 661,545 shares of AstraZeneca worth $129M as of Q1 2026.
  • AstraZeneca was a new Canada Pension Plan Investment Board position in Q1 2026.
  • AstraZeneca made up 0.08% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #220 holding.
  • Canada Pension Plan Investment Board first reported a position in AstraZeneca in Q2 2013 and has held it in 17 quarters since.
  • 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.